Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03649334
Other study ID # R/18.06.213
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date August 26, 2018
Est. completion date October 15, 2018

Study information

Verified date September 2020
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

investigators aim to compare between anaesthetic regimens that included dual-agent (fentanyl and ketorolac) or (ketamine and ketorolac) analgesic therapy


Description:

regarding patient registry; a prior G power analysis was done. Based on the assumption that the pain score in intramuscular ketamine group will be similar to similar to those in previously published data; forty children would be required per group to detect a difference of 30% in CHEOPS pain scores with a power of 90% (α =0.05, β =0.1)

- Statistical analysis: Data will be analyzed through SPSS (Statistical Package for Social Sciences), program version 22. Distribution of data will be first tested by the Shapiro test. Data will be presented as the mean and standard deviation (SD), median and range or numbers and percentages. For normally distributed data, the unpaired t-test will be used to compare the mean values of both groups. For pain and emergence behaviour scores, Mann Whitney U test will be used. Fisher's exact test will be used for comparison of categorical data. The P value ≤ 0.05 will be considered as the level of statistical significance.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date October 15, 2018
Est. primary completion date October 1, 2018
Accepts healthy volunteers No
Gender All
Age group 2 Years to 7 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiologists (ASA) physical status II

Exclusion Criteria:

- Any known allergy to the studied drugs.

- congenital heart disease

- Any cardiac problems.

- Use of psychotropic medication

- mental retardation

- any organ dysfunction

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
ketamine-ketorolac
The patient will receive ketamine 0.5mg.kg-1 + ketorolac 1mk.kg-1 in 2 ml syringe intramuscularly.
fentanyl- ketorolac
The patient will receive fentanyl 1.5ug.kg-1 + ketorolac 1 mg.kg-1 in 2ml syringe intramuscularly

Locations

Country Name City State
Egypt Mansoura University Mansourah DK

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative pain Postoperative pain will be assessed by the CHEOP scale (Children's Hospital of Eastern Ontario Pain Scale)The scale includes six entries with an appropriate point evaluation focused on the character of crying (1-3 points), facial expressions (0-2 points), verbal reaction (0-2 points), position of the body (1-2 points), touch (1-2 points), and position of the legs (1-2 points). Minimum score is 4 (no pain) and maximum is 13 (maximum pain). Grades are summed together. CHEOPS has a minimum possible score of 4 points (no pain) to a maximum of 13 points (the worst pain).
When the postoperative pain score exceeded four, rescue analgesia was given with a 20mg/kg paracetamol suppository.
for 60 minutes later admission to the post-anaesthesia care unit
Secondary Heart rate Heart rate (beat/minute) using ECG monitoring at the baseline (after the induction of anesthesia and before administration of the drugs) then every 5min up to 20 minutes
Secondary systolic blood pressure systolic blood pressure (mmHg) using sphygmomanometer cuff at the baseline (after the induction of anesthesia and before administration of the drugs) then every 5min up to 20 minutes
Secondary The time to the first demand for rescue analgesic The time to the first demand for rescue analgesic (minutes or hours) during first 24 hours postoperative
Secondary total number of children who required postoperative pain medication for 24 hours after surgery
Secondary emergence behavior -emergence behavior will be measured using Aono's four point scale : (1) Asleep; (2) Awake but calm; (3) Agitated but consolable; and (4) Severely agitated and difficult to console and the highest-recorded value was recorded during the Post anesthesia care unit stay. Lowest score is 1 and highest score is 4 The higher score indicates more emergence agitation. For purposes of analysis, grades 1 and 2 in the scale of behavior were considered no agitation and grades 3 and 4 were considered the presence of agitation. every 5 minutes during first 30 minutes of recovery
Secondary nausea, vomiting Number of attacks of nausea and/or vomiting during first 24 hours postoperative
Secondary respiratory difficulty signs of respiratory difficulty:
Breathing rate. An increase in the number of breaths per minute (>35 breath/minute)
Increased heart rate.
Color changes. A bluish color seen around the mouth, on the inside of the lips, or on the fingernails
Grunting. A grunting sound can be heard each time the person exhales.
Nose flaring. The openings of the nose spreading open while breathing
Retractions. The chest appears to sink in just below the neck and/or under the breastbone with each breath-
Sweating. There may be increased sweat on the head, but the skin does not feel warm to
during first 24 hours postoperative